Platinum-Refractory Ovarian Carcinoma

general

Ovarian carcinoma that progresses during platinum therapy or within one month of completing platinum therapy.

39

Centers

41

Active Trials

Cancer Funding

Specific Cancer Types(1)

Top Centers for Platinum-Refractory Ovarian Carcinoma(39)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
High-Volume Research Center
72.1
2
NCI Comprehensive
High-Volume Research Center
72.1
3
High-Volume Research Center
72.1
4
NCI Comprehensive
Active Research Program
50.1
5
NCI Comprehensive
Active Research Program
50.1
6
NCI Comprehensive
Active Research Program
50.1
7
NCI Comprehensive
Active Research Program
50.1
8
NCI Comprehensive
Active Research Program
50.1
9
NCI Comprehensive
Active Research Program
50.1
10
NCI Comprehensive
Active Research Program
50.1
11
NCI Comprehensive
Active Research Program
50.1
1250.1
13
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
50.1
14
NCI Comprehensive
Active Research Program
50.1
15
NCI Comprehensive
Active Research Program
50.1
16
NCI Comprehensive
Active Research Program
50.1
17
NCI Comprehensive
Active Research Program
50.1
18
NCI Comprehensive
Active Research Program
50.1
19
NCI Clinical
Active Research Program
50.1
20
NCI Comprehensive
Active Research Program
50.1
21
Active Research Program
50.1
22
Active Research Program
50.1
23
NCI Comprehensive
Active Research Program
50.1
24
NCI Clinical
Active Research Program
50.1
25
NCI Comprehensive
Active Research Program
50.1
26
Active Research Program
50.1
27
NCI Clinical
Active Research Program
50.1
28
NCI Comprehensive
Active Research Program
50.1
29
Active Research Program
50.1
30
Active Research Program
50.1
3150.1
32
Active Research Program
50.1
33
Active Research Program
50.1
34
Active Research Program
50.1
3550.1
36
Active Research Program
50.1
37
Active Research Program
50.1
38
Active Research Program
50.1
3929.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →